325413

In-Vitro Diagnostic Substance Manufacturing

Cyber Liability Insurance for NAICS 325413

CYB

Ranked reasons a business in NAICS 325413, In-Vitro Diagnostic Substance Manufacturing, needs Cyber Liability coverage. Each reason is specific to how this industry actually loses money, and ends with the question to ask before the objection comes up.

  1. 01

    Wrong test results change patient treatment.

    • Reagents and controls determine whether a diagnostic result is accurate.
    • Manufacturing and testing records establish that performance.
    • A false result means a missed diagnosis or an unnecessary treatment.
    ASK
    What manufacturing and testing records support your product performance claims?
  2. 02

    Products are regulated devices with quality system requirements.

    • Device master records, complaint files, and corrective action records are required.
    • Regulators inspect those records and can act on findings.
    • Adverse event reporting has fixed deadlines.
    ASK
    How are your device master records and complaint files maintained?
  3. 03

    Cold chain determines whether reagents work at all.

    • Reagents are stored and shipped under controlled temperature.
    • Excursions degrade performance invisibly.
    • A degraded reagent produces wrong results with no warning.
    ASK
    Is your reagent storage and shipping temperature monitored and recorded?

1–8 policy ← → move ESC home